
MLND P/E Ratio
P/E Ratio as of Dec 4, 2025: -0.34
Average-0.6224
Median-0.4700
Minimum-0.9800
Maximum-0.3000
-0.34
0.56 (62.22%)past month
The P/E ratio for MLND is -0.34 as of Dec 4, 2025. This represents a decrease of -35.85% compared to its 12-month average P/E ratio of -0.53. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Millendo Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Millendo Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Millendo Therapeutics Inc to industry peers.
Millendo Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Millendo Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Millendo Therapeutics Inc to industry peers.
MLND P/E Ratio Insights
See Millendo Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in MLND
Order type
Buy in
Order amount
Est. shares
0 shares
MLND P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $3.05 | -0.30 |
| Nov 3, 2025 | $10.02 | -0.99 |
| Oct 1, 2025 | $10.15 | -0.69 |
| Sep 2, 2025 | $10.17 | -0.70 |
| Aug 1, 2025 | $7.49 | -0.41 |
| Jul 1, 2025 | $6.90 | -0.38 |
| Jun 2, 2025 | $6.70 | -0.37 |
| May 1, 2025 | $6.85 | -0.35 |
| Apr 1, 2025 | $9.2898 | -0.51 |
| Mar 3, 2025 | $10.1738 | -0.52 |
| Feb 3, 2025 | $11.947 | -0.61 |
| Jan 2, 2025 | $11.1592 | -0.57 |
MLND End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.34 | -39.29% |
| 2024 | -0.56 | -87.44% |
| 2023 | -4.46 | +412.64% |
| 2022 | -0.87 | -61.84% |
| 2021 | -2.28 | +18.13% |
| 2020 | -1.93 | — |
FAQs About Millendo Therapeutics Inc (MLND) P/E ratio
The latest P/E ratio of MLND is -0.34, as of Dec 4, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Millendo Therapeutics Inc’s last 12-month average P/E ratio is -0.53, compared to its current P/E ratio of -0.34. This reflects a decrease of -35.85%.
Millendo Therapeutics Inc’s current P/E ratio of -0.34 is lower than its last 12-month average P/E of -0.53. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Millendo Therapeutics Inc’s average P/E ratio over the last 3 years is -2.09. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Millendo Therapeutics Inc’s average P/E ratio over the last 5 years is -1.97. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.